ArticleBMC medical informatics and decision making2025
Leveraging data-driven insights for esophageal and gastric cancer diagnosis.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOesophago-Gastric Cancer (OGC) and its precursor, high-grade dysplasia (HGD), provide a significant health concern owing to their rapid development and often late diagnosis. Timely identification of individuals is crucial to avert illness advancement and enhance clinical results. Nonetheless, there has been little research on machine learning models and effective statistical techniques for predicting OGC risk.
aimsThis research seeks to uncover risk variables linked to HGD and OGC and to assess the prediction efficacy of several machine learning models using diverse patient data.
methodsThis research used a comprehensive methodology that integrates specialist analysis, statistical modeling, and data visualization. Thorough preprocessing and risk factor identification were conducted for the creation of regression models to forecast OGC and HGD outcomes. Moreover, visual analytics and interactive dashboards were used to improve interpretability and clinical significance.
resultsThe evaluation of the models revealed that the linear regression model exhibited higher performance, with a Mean Squared Error (MSE) of 0.0244, a Mean Absolute Error (MAE) of 0.116, and an R-squared value of 0.046.
conclusionOur results demonstrate the efficacy of machine learning models, namely linear regression, as a dependable instrument for the early risk assessment of OGC and HGD. The integration of predictive modeling, statistical analysis, and dashboarding provides a robust framework that assists healthcare practitioners in diagnosis, treatment, and patient monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.